Born in Arara village the district of Haifa, and attended the Orthodox Arab school for my high-school, specialized in mathematics and physics. I traveled to Saipan, a small island in the norther pacific ocean and lived there for a little more than 2 years, after which attended the Washington State University (WSU), in the field of Pharmacy then switched to Biochemistry. I returned home and attended my graduate studies at the HUJ, focusing my research on head trauma and specifically complication after close head injuries and elevation of ICP. I was employed by D-pharm, a pharmaceutical company developing products for the treatment of neurodegenerative disease, and was responsible for the pharmacological aspects of the developed products. In a joint collaboration with ELLI and Lilly, I was the delegate scientist traveling to Elli & Lilly sites to conduct further investigation on the developed products. After 4 years, decided to continue my academic graduate study to obtain my PhD from the Tel-Aviv University, while my research was focused on co-treatment of diabetes and hypertension, a high prevalence co-morbidities. I joined Pharmaseed as study director and later joined Teva Pharmaceutical leading project development from preclinical POC stages up to clinical submissions to regulatory authorities (FDA). My teaching was limited to TA and SA during my graduate schooling, but always had in mind to peruse an academic career. "Education is preparation for life but life itself"
Academic Experience
| From | To | Present | Position | Institution | Description |
|---|---|---|---|---|---|
| 01/10/1997 | 28/02/1999 | Teaching assistance and Research Assistance position | Hebrew University of Jerusalem | As a graduate student at HUJ, I participated in laboratory practical teaching and assistance; TA/RA | |
| 15/09/2008 | 30/06/2010 | Teaching assistant for several courses | Tel Aviv University | Teaching assistance (TA) position: on different occasions I was of laboratory practical assistance program for student in pharmacology and physiology course. |
Administrative Experience
| From | To | Present | Position | Institution | Description |
|---|---|---|---|---|---|
| 01/02/2012 | 30/04/2013 | Study Director | Pharmaseed Ltd. | Leading experimental studies m at a CRO- Pharmaseed which included all administrative and practical essence of the study, as well managing technical team to perform study outlines according to plans and protocols. Responsible for the study reporting and communication with study sponsor | |
| 01/05/2013 | 20/10/2015 | Research Scientist, and Lab Manager | Tel Aviv University | Research the pharmacological additive effect of SGLT inhibitors and other ARBs on diabetes | |
| 01/11/2015 | 31/12/2020 | Manager, and DMPK Project Lead | Teva Pharmaceuticals | Manager of projects in the preclinical phase and leading the development project from DMPK perspective; an IND enabling. In addition supporting first in human studies, and dose escalation decision making based preclinical data. | |
| 01/06/2021 | 31/10/2022 | Business Development and R&D Manager | Patho-Logica ltd. | Business development including recruiting projects and managing such projects resources and conduct | |
| 01/01/2023 | CEO of NOXON, a start up company for the treatment of IPF (Idiopathic Pulmonary Fibrosis) | New Generation Technology (NGT) in Nazareth | Noxon is a newly formed company based on extensive research in the field of pulmonary fibrosis. The treatment is based on providing antioxidant molecule which is self regenerated, to alleviate the pathological process of fibrosis in the lungs. |
Education
| University/College Name | Degree Received | Specialization | Description |
|---|---|---|---|
| Tel Aviv University | Phd | Pharmacological Research with emphasis on Blood Pressure and Diabetes treatments | During my PhD, I conducted my research on pharmaceutical agents provided by the a pharmaceutical company; Boehringer Ingelheim, intended for the treatment of diabetes, and was suspected to have benenficial effect on the reducing blood pressure. The research was conducted on special animal model, expressing both diabetes and hypertension. Reseach showed that two of the clinically used products, showed beneficial effects in reduced both diabetes and hypertension thus hitting two birds in one stone. |
| Hebrew University of Jerusalem | MSc/MS | Pharmacological Research in Head Trauma | Implication of head trauma model in animals to produce close head injury. The intension was to used anti-inflammatory markers to reduced the trauma induced cranial pressure, which was manifested by neurological improvement. |
| Washington State University, US | BSc/BS | Biochemistry | General Biochemistry undergraduate program at the Washington State University (WSU) |
Skills
Research and Development, PK , PD and TOx assessments, regulatory documents preparation and writing; IB, IND, NDA, project management, computer skills; office (work, excel, PPT), web search, WinnonLin, SPSS, Prisma
Awards
The Institute for Higher Learning of Israel; Three years awarded scholarship for excellent students (granted for Arabs and other Minorities) -2006-9, Yarid Hamahkar, Tel-Aviv University; Awarded certificate honor for best presented poster -2006, Vatat Scholarship, Tel-Aviv University; Awarded based on the merit of achievements and dissertation progress-2009-2010, Dean of School of Medicine, Tel-Aviv University Scholarship of the Dean- 2010
Languages
Arabic
English
Hebrew
English
Hebrew
Courses Taught
| Course Title | Level |
|---|---|
| Structural Biochemistry I for pharmacists | Undergraduate |
| General Biochemistry for Medicine and Dentistry | Undergraduate |
| Clinical Biochemistry- endoreticular system | Undergraduate |
| Structural Biochemistry II for Pharmacists | Undergraduate |
| Biochemistry Laboratory techniques -Pharmacists | Undergraduate |